Cargando…
Modeling the course of Alzheimer's disease to improve clinical trials: symposium report
In a symposium held at the Clinical Trials in Alzheimer's Disease conference in Monte Carlo, Monaco (29 to 31 October 2012) three different, not mutually exclusive approaches to improve and facilitate clinical trials with anti-dementia drugs were presented and discussed. All three approaches ar...
Autores principales: | Spiegel, René, Doody, Rachelle S, Hendrix, Suzanne, Kahle-Wrobleski, Kristin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706927/ https://www.ncbi.nlm.nih.gov/pubmed/23767782 http://dx.doi.org/10.1186/alzrt183 |
Ejemplares similares
-
Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014) -
Requiring an amyloid-β(1-42 )biomarker may improve the efficiency of a study, and simulations may help in planning studies
por: Hendrix, Suzanne B
Publicado: (2011) -
Assessing quality of life in Alzheimer's disease: Implications for clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2016) -
Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
por: Montgomery, William, et al.
Publicado: (2018) -
Improved pathology reporting in NAFLD/NASH for clinical trials
por: Langford, Caitlin Rose, et al.
Publicado: (2022)